South America Ultrasound Gastroscopes Market

ID: MRFR/HC/52355-HCR
200 Pages
Rahul Gotadki
Last Updated: February 06, 2026
South America Ultrasound Gastroscopes Market Research Report By Product Type (Optic Ultrasound Gastroscopes, Others), By Application (Oncology, Others), By Procedure (Upper Endoscopic Ultrasound, Others), By End-user (Hospitals and Clinics, Others), and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

South America Ultrasound Gastroscopes Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)8.27%
2024 Market Size$ 90.04 Million
2025 Market Size$ 97.49 Million
2035 Market Size$ 215.69 Million

Key Players

Olympus Corporation
Fujifilm Holdings Corporation
Medtronic plc
Boston Scientific Corporation
Pentax Medical
Conmed Corporation
Opportunities
  • Investment in Healthcare Infrastructure
  • Growing Awareness of Preventive Healthcare
  • Technological Integration in Medical Practices
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Pharmaceutical, BY Product Type (USD Million)
      1. 4.1.1 Optic Ultrasound Gastroscope
      2. 4.1.2 Linear Array Ultrasound Gastroscope
      3. 4.1.3 Endoscopic Ultrasound Needle
      4. 4.1.4 Others
    2. 4.2 Pharmaceutical, BY Application (USD Million)
      1. 4.2.1 Oncology
      2. 4.2.2 Upper GI Oncology
      3. 4.2.3 Lower GI Oncology
      4. 4.2.4 Pancreatic Conditions
      5. 4.2.5 Others
    3. 4.3 Pharmaceutical, BY Procedure (USD Million)
      1. 4.3.1 Upper Endoscopic Ultrasound (EUS)
      2. 4.3.2 Lower Endoscopic Ultrasound (EUS)
      3. 4.3.3 Endoscopic Ultrasound-Guided Fine-Needle Aspiration
      4. 4.3.4 Others
    4. 4.4 Pharmaceutical, BY End-User (USD Million)
      1. 4.4.1 Hospitals and Clinics
      2. 4.4.2 Ambulatory Surgical Centers
      3. 4.4.3 Others
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Olympus Corporation (JP)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Fujifilm Holdings Corporation (JP)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Medtronic plc (IE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Boston Scientific Corporation (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Pentax Medical (JP)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Conmed Corporation (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Hoya Corporation (JP)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Smith & Nephew plc (GB)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
    3. 6.3 SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    4. 6.4 SOUTH AMERICA MARKET ANALYSIS BY PROCEDURE
    5. 6.5 SOUTH AMERICA MARKET ANALYSIS BY END-USER
    6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
    9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
    11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
    12. 6.12 PHARMACEUTICAL, BY PRODUCT TYPE, 2024 (% SHARE)
    13. 6.13 PHARMACEUTICAL, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
    14. 6.14 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
    15. 6.15 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
    16. 6.16 PHARMACEUTICAL, BY PROCEDURE, 2024 (% SHARE)
    17. 6.17 PHARMACEUTICAL, BY PROCEDURE, 2024 TO 2035 (USD Million)
    18. 6.18 PHARMACEUTICAL, BY END-USER, 2024 (% SHARE)
    19. 6.19 PHARMACEUTICAL, BY END-USER, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
      3. 7.2.3 BY PROCEDURE, 2025-2035 (USD Million)
      4. 7.2.4 BY END-USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

South America Pharmaceutical Market Segmentation

Pharmaceutical By Product Type (USD Million, 2025-2035)

  • Optic Ultrasound Gastroscope
  • Linear Array Ultrasound Gastroscope
  • Endoscopic Ultrasound Needle
  • Others

Pharmaceutical By Application (USD Million, 2025-2035)

  • Oncology
  • Upper GI Oncology
  • Lower GI Oncology
  • Pancreatic Conditions
  • Others

Pharmaceutical By Procedure (USD Million, 2025-2035)

  • Upper Endoscopic Ultrasound (EUS)
  • Lower Endoscopic Ultrasound (EUS)
  • Endoscopic Ultrasound-Guided Fine-Needle Aspiration
  • Others

Pharmaceutical By End-User (USD Million, 2025-2035)

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others